本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioLine Rx

3.25
-0.1900-5.52%
盘后3.24-0.0100-0.31%16:05 EDT
成交量:1.84万
成交额:6.10万
市值:1,209.33万
市盈率:-0.70
高:3.43
开:3.43
低:3.24
收:3.44
数据加载中...
2025/03/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/26

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/03/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/27

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/03/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/20

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/09

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/26

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/23

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/23

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/20

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/19

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses